Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2-, node-positive, high-risk early breast cancer in Italy.
Glob Reg Health Technol Assess. 2023 Sep 28;10:62-69. doi: 10.33393/grhta.2023.2561. eCollection 2023 Jan-Dec.
Glob Reg Health Technol Assess. 2023.
PMID: 37811343
Free PMC article.
Cite
Cite